Status:
COMPLETED
Safety Surveillance of MenACWY-CRM Vaccine in Children
Lead Sponsor:
Novartis Vaccines
Conditions:
Meningococcal Disease
Eligibility:
All Genders
2-10 years
Brief Summary
The purpose of this study is to summarize the occurrence of incident serious medically attended events and events of interest up to 1 year following MenACWY-CRM vaccination administered as part of rou...
Detailed Description
This is an observational study, vaccines administration and data that is collected is only as part of routine clinical care. Vaccinated subjects are not actively recruited. Events of Interest: Diabet...
Eligibility Criteria
Inclusion
- Registered with the HMO for at least 6 months prior to vaccination.
- Between the ages of 2 and 10 years (inclusive - i.e. has not reached their 11th birthday) at the time of the vaccination.
- Received any MenACWY-CRM vaccination during the vaccination period at the participating centers.
Exclusion
- None
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
393 Patients enrolled
Trial Details
Trial ID
NCT01452438
Start Date
September 1 2011
End Date
July 1 2015
Last Update
August 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente South California
Pasadena, California, United States, 91101